03:36 AM EDT, 07/10/2024 (MT Newswires) -- Evotec (EVO) said Wednesday it has entered a multi-year research collaboration and option agreement with Pfizer ( PFE ) .

The company said the partnership will initially target early discovery research in metabolic and infectious diseases at Evotec's facilities in France.

Pfizer ( PFE ) will provide research support funding to Evotec, with potential milestones and royalties based on program success.

Financial terms weren't disclosed.

Price: 5.10, Change: -0.02, Percent Change: -0.39